Advancements in technology, such as digital cytology and molecular cytogenetics, are expected to enhance the diagnostic accuracy and efficiency of cytological methods. These advancements will likely play a significant role in the future of personalized cancer treatment, enabling more precise and tailored therapeutic approaches.